ロード中...
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities
Engineered T cell therapies such as chimeric antigen receptor (CAR) expressing T cells (CAR-T cells) have great potential to treat many human diseases; however, inflammatory toxicities associated with these therapies present safety risks and can greatly limit its widespread use. This article briefly...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250150/ https://ncbi.nlm.nih.gov/pubmed/34220853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.693016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|